Polyunsaturated fatty acids, vitamin E, and the proliferation of aortic smooth muscle cells.
D015117:5,8,11,14-Eicosatetraynoic Acid / Q000494:pharmacology; D015126:8,11,14-Eicosatrienoic Acid / Q000494:pharmacology; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001011:Aorta / Q000187:drug effects; D002110:Caffeine / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D006168:Guinea Pigs; D007213:Indomethacin / Q000494:pharmacology; D009130:Muscle, Smooth / Q000166:cytology* / Q000187:drug effects; D010208:Papaverine / Q000494:pharmacology; D011458:Prostaglandins E / Q000378:metabolism; D011460:Prostaglandins F / Q000494:pharmacology; D014810:Vitamin E / Q000494:pharmacology*
D000975:Antioxidants; D005231:Fatty Acids, Unsaturated; D011458:Prostaglandins E; D011460:Prostaglandins F; D015117:5,8,11,14-Eicosatetraynoic Acid; D014810:Vitamin E; D002110:Caffeine; D010208:Papaverine; D015126:8,11,14-Eicosatrienoic Acid; D007213:Indomethacin